2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology…
By V. Fuster, L. Rydén, Davis S. Cannom, H. Crijns, A. Curtis, K. Ellenbogen, J. Halperin, G. Kay, Jean-Yves Le Huezey, J. Lowe and 26 more. Circulation, 2011
1,867 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Economics and Econometrics
View Paper: https://www.semanticscholar.org/paper/e188affc63f84131a18cdcea88a34eb2f291d6f3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Guidelines for the Primary Prevention of Stroke (2011, neutral): “The 2013 ACCF/AHA guideline for the management of ST-segment–elevation MI (STEMI) states that anticoagulant therapy with a vitamin K antagonist is reasonable for patients with STEMI and asymptomatic left ventricular mural thrombi (Class IIa; Level of Evidence C) and that anticoagulant therapy may be”
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi (2011, methodology): “For a more detailed description of the manageent of subjects with postoperative AF, the reader is eferred to the 2011 ACCF/AHA/HRS guidelines for the anagement of Patients with Atrial Fibrillation (608).”
- Dilated Cardiomyopathy: Genetic Determinants and Mechanisms (2017, neutral): “such as history of hypertension, diabetes mellitus, previous stroke or transient ischemic attack, or ≥75 years of age.(149)”